Watchlist

Watchlist
ADMA Biologics Inc (ADMA)
ADMA Biologics Inc (ADMA)
ADMA files BLA for its third plasma collection center
ADMA Biologics (NASDAQ: ADMA ) announces the filing of a Biologics License Application (BLA) for its third plasma collection center located in Kennesaw, Georgia. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more …
ADMA Biologics: Can We Trust This ~$3 Biotech Stock Again?
"How much easier it is to be critical than to be correct." - Benjamin Disraeli Today, we revisit a name I have not profiled in quite some time. However, it has seen additional insider buying in recent weeks and I have gotten a few inquiries from followers on it so far in November Compan…
Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Gilead Sciences Today we will discuss…
Daily Insider Ratings Round Up 11/13/17: ADMA, S
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "…
Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge
This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will discuss an article …
Premarket analyst action - healthcare
Sucampo Pharmaceuticals (NASDAQ: SCMP ) initiated with Buy rating and $14 (36% upside) price target by B. Riley. More news on: Sucampo Pharmaceuticals, Inc., TG Therapeutics, Inc., Perrigo Company, Healthcare stocks news, Stocks on the move, Read more …
Your Daily Pharma Scoop: Progenics Looks Promising, Big Week For Dynavax, Keryx Ahead Of Catalyst
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Progenics Pharmaceuticals Today we …
ADMA Biologics EPS of -$0.59
ADMA Biologics (NASDAQ: ADMA ): Q3 EPS of -$0.59 may not be comparable to consensus of -$0.42. Revenue of $4.73M (+60.9% Y/Y) misses by $1.73M . Press Release More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, ,
ADMA Biologics (ADMA) Presents At Ladenburg Thalmann 2017 Healthcare Conference - Slideshow
The following slide deck was published by ADMA Biologics Inc in conjunction with this Read more …
ADMA Biologics EPS of -$0.55
ADMA Biologics (NASDAQ: ADMA ): Q2 EPS of -$0.55 may not be comparable to consensus of -$0.26. Revenue of $3.4M (+49.8% Y/Y) beats by $0.14M . Press Release More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, ,
ADMA Biologics Follows Up On RI-002
ADMA Biologics (ADMA) is a company with a market cap ranging from $100 million to $200 million in the past year, focused on developing innovative products for patients prone to infection. The company develops plasma-based biologics candidates for treatment of Primary Immune Deficiency Diseas…
ADMA Biologics Inc (ADMA)